About this source
- Kind
- Regulatory or official document
- Primary or secondary
- primary
- Peer review
- not peer reviewed
- Retraction status
- None known
- Date checked
- 14 November 2026
Limitations
The index lists active substances in UK-authorised products on the date checked. Absence from the index is a search result on that date, not a regulatory decision. Teriparatide, abaloparatide, afamelanotide, setmelanotide, semaglutide, tirzepatide, liraglutide and oxytocin were all present on the same date, which confirms the index was working.
Cited in
UK regulatory status
Afamelanotide · UK regulatory status
UK regulatory status
AOD-9604 · UK regulatory status
UK regulatory status
BPC-157 · UK regulatory status
UK regulatory status
CJC-1295 · UK regulatory status
UK regulatory status
Elamipretide · UK regulatory status
UK regulatory status
Epithalon · UK regulatory status
UK regulatory status
GHRP-2 · UK regulatory status
UK regulatory status
GHRP-6 · UK regulatory status
UK regulatory status
Hexarelin · UK regulatory status
UK regulatory status
Ipamorelin · UK regulatory status
UK regulatory status
Kisspeptin · UK regulatory status
UK regulatory status
KPV · UK regulatory status
UK regulatory status
MOTS-c · UK regulatory status
UK regulatory status
Selank · UK regulatory status
UK regulatory status
Semax · UK regulatory status
UK regulatory status
TB-500 · UK regulatory status
UK regulatory status
Thymosin beta-4 · UK regulatory status
Spotted an error? Report a problem with this page. We correct the record and log every change on What's changed.